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Abstract 
This article focuses on airborne engineered nanoparticles generated in a growing number of 
commercial and research facilities. Despite their presence in the air of many such facilities, 
there are currently no established and validated measurement methods to detect them, 
characterise their properties or quantify their concentrations. In relation to their possible 
health impacts, the key questions include: (i) Are the particles in the nano-size range are more 
toxic than larger particles of the same material? (ii) Does the surface chemistry of the lung 
alters the toxicity of inhaled nanoparticles? (iii) Do nano-fibers pose the same risk as 
asbestos? and (iv) Are the methods for assessing the health risk are appropriate? This article 
summarises the state of knowledge in relation to these issues.  
 
Engineered nanoparticles within the world of ambient particles 
The beginning of the twenty-first century has witnessed an explosion of interest in the science 
and technology of engineered nanoparticles. For example, this is reflected in the 2008 NSW 
Government Enquiry into Nanotechnology (Catanzariti 2008) which states that: 
“Nanotechnology has the potential to fundamentally alter the way people live - to grow new 
industries and to transform existing areas”. Nanotechnology and nanomaterials are, and will 
be, of crucial significance in most fields of human endeavour, as both new products and as 
“enabling technology” to improve current products, including (Catanzariti 2008): biomedical 
devices and health; electronics, information technology and communications; packaging and 
logistics; food and agribusiness; automotive production; power and energy; environment 
monitoring and maintenance;  mining, mineral exploration and mineral processing; scientific 
instruments; security and defence; cosmetics; sporting equipment; clothing; building and the 
built environment; and biotechnology. This clearly indicates that nanotechnology is 
ubiquitous and indispensable. However, it has also been realised that these materials can 
escape into the environment, and along with an increasing demand for nanomaterials, in 
terms of both quantity and quality, there have also been growing concerns regarding their 
potential impacts on human health and demands for government to regulate the safety of 
nanotechnology. 
My previous articles in this series explored the topic of airborne particles and health, 
and concluded that there are major gaps in knowledge in relation to the impact of the ultrafine 
(UF) particles on health, with an acute deficiency of sound epidemiological evidence 
(Morawska 2010). This article focuses on an apparently even smaller size range of particles: 
nanoparticles. But are they really smaller? According to the International Standards 
Organisation (ISO), ISO/TC 146/SC 2/WG1 N 320 defines a nanoparticle as: “A particle with 
a nominal diameter smaller than about 100 nm”. However, the same document defines an 
ultrafine particle as: “A particle sized about 100 nm in diameter or less”. This illustrates the 
fact that different terminology, employed in different fields of particle investigation, is being 
used for particles of the same size! In contrast to the fields of ambient aerosol or combustion 
emissions science which refer to “ultrafine particles”, “engineered nanoparticle” is the 
preferred term when describing nanosize particles originating from various manufacturing or 
engineering processes. Therefore, it stands to reason that since epidemiological evidence in 
relation to UF particles is so limited, and since these particles have been investigated for 
longer that the relatively new engineered nanoparticles, both in terms of their presence in 
ambient systems and their health effects, epidemiological evidence relating to the latter is 
expected to be even more limited.    
 
Classification of nanoparticles 
In broad terms, engineered nanoparticles are generated by one of four processes: 1) 
mechanical (grinding), 2) wet production, 3) vapour deposition synthesis, and 4) gas-phase 
processes (Aitken et al. 2004). They are easily emitted into the surrounding environment, 
especially during the latter two processes. According to the classification proposed by the 
British Standards Institute (BSI 2007), nanomaterials fall into four groups: (1) Fibrous, with a 
high aspect ratio of insoluble nanomaterial; (2) CMAR, nanomaterial which, in its larger 
particle form, is already classified as carcinogenic (C), mutagenic (M), asthmagenic (A) or a 
reproductive toxin (R); (3) Insoluble, which are insoluble or poorly soluble nanomaterials; 
and (4) Soluble, which are not in (1) or (2). Particular attention has been directed to 
potentially highly hazardous nanomaterials classified as nanofibres [Group (1)], with carbon 
nanotubes being well known members of this group. Concern has been expressed regarding 
inhalation of nanofibres because they  posses many similar toxicological traits to asbestos and 
other biopersistent fibres, including a large aspect ratio, poor solubility and the ability to 
cause “asbestos-like” injury to lung tissue (Poland et al. 2008; Takagi et al. 2008).  
 Exposure to engineered nanoparticles 
In the first instance, exposure to engineered nanoparticles should be considered in the 
facilities where they are generated. The estimated number of such facilities in NSW is 
between 23-40 (Catanzariti 2008), and we have identified over 20 in South East Queensland 
(SEQ) to date. However, a quantitative understanding of exposure to these particles, which 
have, for example, either escaped from the reactor into the air or been generated on the 
laboratory bench without any reactor, is extremely limited. While potential detection methods 
for airborne engineered nanoparticles are yet to be validated, there is already evidence of the 
presence of these particles in nanotechnology facilities. There have been only a handful of 
studies conducted in facilities where engineered nanoparticles are formed, which included 
measurements of size distribution, concentration, mass and physico-chemical characterisation 
of the particles (Maynard et al. 2004; Demou et al. 2008; Han et al. 2008; Seipenbusch et al. 
2008; Yeganeh et al. 2008). Most of these studies, which were conducted in the ambient air 
of the facility, showed an increase in particle concentration, which was usually higher closer 
to the production site. This elevation in concentration, even if small, is of significant concern 
due to the unknown health effects of these particles. Within the handfull of studies on this 
topic, there are no conclusive answers to the level of exposure, in many cases due to the 
design of the studies, which either did not account for inherent variation in the nanoparticles 
generation process itself, or did not account for the background and other processes (which 
may have obscured the impact of the engineered nanoparticles) taking place in the facilities 
investigated. As concluded by the Royal Academy of Engineering (RSRAE 2004), 
occupational monitoring of exposure during nanoparticle production is still in its infancy, 
with many uncertainties regarding an appropriate metric and empirical method.  
 
Detection and monitoring of engineered nanoparticles 
A prerequisite of effective exposure risk assessment and, in turn, the prevention of health 
effects, is the existence of instruments, scientifically validated methods and traceable 
standards to detect, characterise and quantify the particles in the air. Our recent review on the 
topic of nanoparticle monitoring showed that the demand for quantitative methods to 
characterise airborne nanoparticles has led to significant progress in the design and 
manufacture of the fast response instruments required for detecting and characterising 
individual nanoparticles (Morawska et al. 2009). These instruments are now capable of 
counting and size classifying the particles in real time, and also of providing insight into 
particle structure and chemical composition. The new generation of condensation particle 
counters, time-of-flight aerosol mass spectrometers or systems such as 
Volatilization/Humidification Tandem Differential Mobility Analysers, enable sufficient 
insight into the physico-chemical nature of nanoparticles, so that the science of nanoparticle 
formation, as well as their post-formation dynamics, can be revealed. However, the 
application of many of these techniques: (i) is still in the research domain rather than in 
everyday use; (ii) requires knowledge and experience to provide meaningful data; and (iii) 
are not conducive to personal monitoring of workers due to the large size of the 
instrumentation. In addition, validation of monitoring methods must be conducted for 
detection of engineered nanoparticles. Currently, no such framework is available to health 
and safety personnel, who have minimal guidance regarding the monitoring of workplace 
nanoparticles, if they indeed choose to monitor nanoparticles at all. To date, the range of 
instrumental techniques available to the field of aerosol science for particle measurement 
have not been employed and validated for routine assessment of the risks posed by 
engineered nanoparticles exposure, and the monitoring of nanoparticles in the air is 
practically non-existent in the facilities surveyed to date. In addition, the fundamental issue of 
which particle metrics should be monitored to best assess human health risk is far from being 
resolved. Is it particle morphology, number, mass or surface area, as a function of particle 
size, particle composition or degree of particle agglomeration, or a combination of these, 
which is of significance to health risk assessment? 
 
Health effects 
As I have explained in relation to UF particles (Morawska 2010), potential hazards resulting 
from the inhalation of nanoparticles are very different to those of larger particles, as they are 
not readily removed (by impaction and interception) from the airstream of inhaled air in the 
upper parts of the respiratory tract and are inhaled into much deeper regions of the lung. One 
of the first studies which alerted to the risks of inhaling very small particles and stimulated 
research on ambient UF particle toxicology, showed that inhaling TiO2 particles below 50 
nm in diameter led to a significant increase in pulmonary inflammation in rats (Oberdorster et 
al. 1995). Based on this, the authors recommended that: “Since ultrafine particles are always 
present in the urban atmosphere, we suggest that they also play a role in causing acute lung 
injury in sensitive parts of the population.” Of course, TiO2 is not naturally present in 
ambient air, but it is one of the most widely used engineered nanomaterials, and is present in 
a large range of products available today.  
The key questions in relation to the potential health effects of engineered nanoparticles 
include: 
1. Are particles in the nano-size range more toxic than larger particles of the same 
material? 
2. Does the surface chemistry of the lung alter the toxicity of inhaled nanoparticles?  
3. Do nano-fibers pose the same risk as toxic fibres such as quartz and asbestos? 
4. Are we assessing the health risk appropriately?  
 
At this point in time, all of the existing evidence and partial answers to the above 
questions come from toxicology studies, with several review papers published on this topic. 
For example, in relation to the Australian context, Safe Work Australia (SWA 2009) analysed 
scientific literature from 2006 to 2009, with a focus on the nanomaterials being researched, 
manufactured or used in Australia.  
Regarding the toxicity of smaller particle versus larger particles of the same material, 
while there have been some studies indicating that the former are more toxic than the latter 
(Faux et al. 2003), according to a comprehensive review published by Safe Work Australia 
(SWA 2009), there was no persuasive evidence found supporting this theory. However, it was 
acknowledged that, in relation to most engineered nanoparticles, studies that would look at a 
wide variety of acute and chronic endpoints have not yet been conducted. Nevertheless, it has 
been demonstrated that, in general, nanoparticles are more bio-reactive and therefore likely to 
be more toxic than larger particles of the same material. It appears that while resulting in a 
comparable spectrum of in vivo toxicities to larger particles, lower mass doses for smaller 
particles is required to achieve the same effect. Overall, the whole process is very 
complicated, and further dimensions of complication come from the question of bio-
persistence of these materials in the lung, as well as the complex layered structure of some of 
the materials, resulting in a surface coating that is different to the core of the particle (which 
is of vital importance in relation to interaction with the lung lining).  
In general, there appears to be sufficient evidence that all bio-persistent nano-fibers 
(carbon nanotubes and their aggregates) are a potential fibrogenic and mesothelioma hazard, 
as shown by several recent studies, including Poland et al (Poland et al. 2008), Takagi et al 
(Takagi et al. 2008), Porter et al (Porter et al. 2009) or Ryman-Rasmussen et al (Ryman-
Rasmussen et al. 2006), as well as by the recent review published by Safe Work Australia 
(SWA 2009). However, this is in contrast to some other types of engineered nanoparticles 
investigated. For example, in relation to fullerenes (any molecule composed entirely of 
carbon, in the form of a hollow spheres, ellipsoid or tube), which are not nanotubes, several 
toxicological studies concluded that they appear to be less hazardous than other carbon based 
nanoparticles (Fiorito et al. 2006; Hamilton et al. 2007; Baker et al. 2008; SWA 2009). 
Another example is the toxicity of quantum dots (QD) (nanometre size particles of 
semiconductor crystalline material, that exhibit size dependent properties due to quantum 
confinement effects on the electronic states (Ryman-Rasmussen et al. 2006)), which have 
been shown to depend on multiple factors relating to both inherent physicochemical 
properties and environmental conditions, including size, charge, concentration, outer coating 
bioactivity, and oxidative, photolytic and mechanical stability (Hardman 2006).  
 With so many unanswered questions in relation to nanoparticle toxicity, the question 
of whether we assess the health risk appropriately is still an open one. For example, Safe 
Work Australia (SWA 2009) concluded that: “There have been numerous in vitro 
experiments performed with a wide range engineered nanoparticles that have shown a 
number of effects. However, on their own, these results are not sufficient for assessing health 
risks in the workplace.” 
There are fewer questions in relation to the findings from epidemiology – simply 
because there have been hardly epidemiological studies published on this topic. One article 
published last year, which reported on seven Chinese factory workers of an unidentified 
printing factory who developed severe lung damage from inhaling nanoparticles (two of them 
later died), opened a Pandora’s Box of doubt and speculation (Song et al. 2009). All seven of 
the workers were reported to have had pleural granulomas (ball-like collections of immune 
cells in the lining of the lung that form when the immune system is unable to remove a 
foreign body), as well as excessive discoloured fluid in the lung lining. In their lung fluid and 
tissue, particles of approximately 30 nanometres in size were also identified. The study 
related the symptoms to inhalation of fumes produced when heating polystyrene boards, 
previously sprayed with a 'paste material' made from a plastic identified as a polyacrylate 
ester to 75–100Ԝ°C. However, a group of credible experts expressed doubts as to the 
robustness of the research, and whether the nanoparticles were in fact the reason for ill health 
or whether other factors were to blame (Gilbert 2009). In particular, the study did not identify 
the actual nanoparticles or their concentrations arising from the work processes involved, 
therefore making it difficult to link the effects to the exposures. It was also suggested that the 
symptoms were more typical of chemical exposure.  
Thus, it is not that epidemiology is still to deliver the final chapter, rather, the opening 
chapter on engineered nanoparticles is yet to be written or even formatted!  
 
Current directions 
Every month brings more publications, new toxicological studies, reports by various 
organisations from around the world on nano-safety issues, as well as new reviews and re-
reviews of published studies. However, as disused above, limitations of the existing 
knowledge are quite severe, which gives basis to speculations, and in turn, makes it difficult 
to separate facts from opinions.     
In absence of concrete medical evidence of adverse health effects from exposure to 
engineered nanoparticles, the precautionary approach is consistently recommended by 
governments across the world. For example, the British Standard Institute guide (BSI 2007) 
recommended two precautionary approaches, including the use of quantitative Benchmark 
Exposure Levels (BELs), and guidance for the control of engineered nanoparticle exposure in 
the workplace based on control banding. The BELs have been recommended for the four 
abovementioned nanomaterial types, and while specific BEL values can be find in the 
document, it is of interest to note that, in relation to insoluble materials, an alternative 
approach was also suggested, based on a benchmark related to particle number concentration. 
Since current urban pollution in the UK ranges from 20,000 to 50,000 particles/ml (normally 
referred to as particles/cm3), it has been suggested that the lower end of this range be used to 
discriminate engineered nanoparticles from ambient environmental particle concentrations.   
It is an interesting concept and the appropriateness of this concentration level as a 
benchmark for the nanotechnology industry should probably be discussed further. However, 
returning to the issue of ambient ultrafine particles, being nanoparticles to which we are all 
exposed on daily basis, should we also consider this as an environmental safety benchmark? 
It is not only in the UK cities where such levels of ambient particle concentrations are 
encountered (see our review on particle number concentration levels in different 
environments (Morawska et al. 2008)), and perhaps this level would also be appropriate to 
demarcate between relatively clean and traffic affected environments. But this is a different 
discussion...  
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